WEST PHARMACEUTICAL SERVICES, INC. Repayments of Convertible Debt
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Repayments of Convertible Debt of $165.50 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2013-02-27
- WEST PHARMACEUTICAL SERVICES, INC. repayments of convertible debt for the quarter ending 2012-12-31 was -$100.00K.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of convertible debt for the quarter ending 2012-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of convertible debt for the quarter ending 2011-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of convertible debt for the quarter ending 2011-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of convertible debt for fiscal 2012 was $165.50M.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of convertible debt for fiscal 2011 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of convertible debt for fiscal 2010 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$100.00K derived: sum of 2 quarters · filed 2013-02-27 | $165.50M 10-K · filed 2013-02-27 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $165.60M 10-Q · filed 2012-11-05 | ||
| 2012-06-30 | $165.60M 10-Q · filed 2012-08-06 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $0.00 10-K · filed 2013-02-27 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $0.00 10-Q · filed 2012-11-05 | ||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-06 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |